Axonal transport and Alzheimer's disease

被引:233
|
作者
Stokin, Gorazd B. [1 ]
Goldstein, Lawrence S. B.
机构
[1] Univ Ljubljana, Med Ctr, Div Neurophysiol, Inst Clin Neurophysiol, SI-1525 Ljubljana, Slovenia
[2] Univ Calif San Diego, Sch Med, Howard Hughes Med Inst, Dept Cellular & Mol Med, La Jolla, CA 92093 USA
关键词
motor proteins; axons; axonal pathology; aging; neurodegeneration;
D O I
10.1146/annurev.biochem.75.103004.142637
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In contrast to most eukaryotic cells, neurons possess long, highly branched processes called axons and dendrites. In large mammals, such as humans, some axons reach lengths of over I m. These lengths pose a major challenge to the movement of proteins, vesicles, and organelles between presynaptic sites and cell bodies. To overcome this challenge axons and dendrites rely upon specialized transport machinery consisting of cytoskeletal motor proteins generating directed movements along cytoskeletal tracks. Not only are these transport systems crucial to maintain neuronal viability and differentiation, but considerable experimental evidence suggests that failure of axonal transport may play a role in the development or progression of neurological diseases such as Alzheimer's disease.
引用
收藏
页码:607 / 627
页数:21
相关论文
共 50 条
  • [31] Copper transport and Alzheimer's disease
    Macreadie, Ian G.
    EUROPEAN BIOPHYSICS JOURNAL WITH BIOPHYSICS LETTERS, 2008, 37 (03): : 295 - 300
  • [32] Copper transport and Alzheimer’s disease
    Ian G. Macreadie
    European Biophysics Journal, 2008, 37 : 295 - 300
  • [33] Homeostatic plasticity of axonal excitable sites in Alzheimer's disease
    Quintela-Lopez, Tania
    Lezmy, Jonathan
    FRONTIERS IN NEUROSCIENCE, 2023, 17
  • [34] Axonal length correlates with dementia severity in Alzheimer's disease
    Anderson, B
    MEDICAL SCIENCE RESEARCH, 1996, 24 (04): : 271 - 273
  • [35] Huntington's disease: Huntingtin and the control of axonal transport
    Zala, D.
    Liot, G.
    Humbert, S.
    Saudou, F.
    JOURNAL OF NEUROCHEMISTRY, 2009, 110 : 60 - 60
  • [36] Fast axonal transport alterations in Parkinson's disease
    Morfini, G
    Pigino, G
    Chilcote, T
    Serulle, Y
    Sugimori, M
    Llinas, R
    Brady, S
    JOURNAL OF NEUROCHEMISTRY, 2006, 96 : 144 - 144
  • [37] Identification of Axonal Transport Biomarkers in Parkinson's Disease
    Chadwick, Christine W.
    Aminoff, Michael J.
    Wong, Po-Yin A.
    Husted, Kristofor H.
    Liu, Shanshan
    Liu, Victoria M.
    Kohlstaedt, Lori A.
    Protasio, Johan
    Riff, Timothy
    Boban, Drina
    Killian, Maudi
    Epling, Lorrie
    Sinclair, Elisabeth
    Peterson, Julia
    Price, Richard
    Hellerstein, Marc K.
    Farnara, Patrizia
    ANNALS OF NEUROLOGY, 2012, 72 : S93 - S94
  • [38] Glucocorticoid hormone (cortisol) affects axonal transport in human cortex neurons but shows resistance in Alzheimer's disease
    Dai, JP
    Buijs, R
    Swaab, D
    BRITISH JOURNAL OF PHARMACOLOGY, 2004, 143 (05) : 606 - 610
  • [39] Microtubule-stabilising drugs for therapy of Alzheimer's disease and other neurodegenerative disorders with axonal transport impairments
    Trojanowski, JQ
    Smith, AB
    Huryn, D
    Lee, VMY
    EXPERT OPINION ON PHARMACOTHERAPY, 2005, 6 (05) : 683 - 686
  • [40] Cyclophilin D Deficiency Rescues Axonal Mitochondrial Transport in Alzheimer's Neurons
    Guo, Lan
    Du, Heng
    Yan, Shiqiang
    Wu, Xiaoping
    McKhann, Guy M.
    Chen, John Xi
    Yan, Shirley ShiDu
    PLOS ONE, 2013, 8 (01):